U.S. Stocks on a Downfall, Topping 2012’s Biggest Weekly Decline

U.S. Stocks on a downfall

U.S. Stocks on a downfall

Stocks fell leading S&P end its worst week of the year as growing pressure on Europe’s debt markets revitalized concerns about the region’s financial stability. The Dow Jones industrial average and Standard & Poor’s 500-stock index dropped, falling for a third straight day. But Nasdaq advanced modestly, buoyed by retailer Bed Bath & Beyond. The stock jumped nearly 10 percent to a lifetime high a day after the company’s quarterly results beat analysts’ forecasts.

The concerns about the euro zone, particularly Spain, overshadowed what is expected to be a solid U.S. jobs report Friday.

The S&P 500’s loss for the week, 0.7 percent, was its biggest weekly decline of the year as yields on Spain’s debt continued to march higher and its equity market plumbed lows not seen since the height of the euro zone’s crisis last year.

Economists are expecting the nonfarm payroll report due to show that the U.S. economy added 203,000 jobs in March. That would represent a fourth-straight month of solid job creation, marking the longest stretch of monthly employment gains topping 200,000 since 1999.

The Dow dropped 14.61 points, or 0.11 percent, to 13,060.14 at Thursday’s close. The S&P dipped 0.88 of a point, or 0.06 percent, to 1,398.08. But Nasdaq gained 12.41 points, or 0.40 percent, to 3,080.50.

The cash U.S. stock market is closed for the Good Friday holiday when the payroll data is set to be released; CME futures will trade for an abbreviated 45-minute session. The U.S. bond market will be open until noon.

The recent losses for stocks are slim, but traders are becoming concerned about the potential for a more severe retreat heading into the seasonally weak period starting in May.

Seth Setrakian, co-head of U.S. equities at First New York Securities said, “Over the last couple of days, a small sense of trepidation came back in that the market is able to correct, and people are kind of reevaluating their books, saying, where do I want to be positioned over the next three- to six-month horizon now that you’ve had such a great past six months” .

Shares of a few retailers’ have advanced after the companies reported March same-store sales that topped forecasts as mild weather and an early Easter prompted consumers to shop for summer clothes and other seasonal items. The stronger than expected sales in March prompted some retailers to raise their profit expectations for the quarter.

Shares of TJX , which operates the T.J.Maxx and Marshalls low-price chains, gained 2.4 percent to $40.29. The S&P retail index advanced 0.7 percent. At the close, Bed Bath & Beyond was up 8.5 percent at $71.85, near its all-time high of $72.75 hit earlier in the day.

 

Dhwani Shah

Recent Posts

Bayer snaps up biotech firm Vividion Therapeutics for $2 billion

Bayer snaps up biotech firm Vividion Therapeutics for $2 billion

Bayer AG is in talks to buy Vividion Therapeutics in a roughly $2 billion deal, enforcing new IPO plans for Vividion.
2 hours ago
Auto Industry Leaders push EV plans to maintain leadership

Auto Industry Leaders push EV plans to maintain leadership

Auto Industry Leaders push EV plans ahead to raise new outcomes by 2030. Environmentalists also add to the bar by shaking things with vehicle emission rules by 2026.
5 hours ago
General Motors Q2 2021 Results Recap

General Motors Q2 2021 Results Recap

General Motors Q2 earnings and revenue missed Wall Street’s expectations even though the world’s leading automaker beat earnings projections.
1 day ago
UK casts doubt over Nvidia’s Arm acquisition over security risks

UK casts doubt over Nvidia’s Arm acquisition over security risks

UK considers blocking Nvidia’s Arm acquisition due to potential risks to national security. The $40 billion takeover faces similar fate in America, China and the European Union.
1 day ago
PepsiCo relinquishes control of Tropicana for $3.3 billion

PepsiCo relinquishes control of Tropicana for $3.3 billion

PepsiCo will sell Tropicana and other juice brands to a private equity firm in exchange for pre-tax proceeds of 3.3 billion dollars.
2 days ago
Sanofi bets big on mRNA future with Translate Bio acquisition offer

Sanofi bets big on mRNA future with Translate Bio acquisition offer

Sanofi’s CEO Paul Hudson is dead serious about mRNA technology and capabilities with a $3.2 billion acquisition offer to Translate Bio.
2 days ago